Dixie W. Esseltine
About
In The Last Decade
Dixie W. Esseltine
19 papers receiving 565 citations
Peers
Comparison fields: 5 of 67
- Hematology 368
- Genetics 206
- Immunology 97
- Pediatrics, Perinatology and Child Health 85
- Pulmonary and Respiratory Medicine 74
Countries citing papers authored by Dixie W. Esseltine
This map shows the geographic impact of Dixie W. Esseltine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dixie W. Esseltine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dixie W. Esseltine more than expected).
Fields of papers citing papers by Dixie W. Esseltine
This network shows the impact of papers produced by Dixie W. Esseltine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dixie W. Esseltine. The network helps show where Dixie W. Esseltine may publish in the future.
Co-authorship network of co-authors of Dixie W. Esseltine
This figure shows the co-authorship network connecting the top 25 collaborators of Dixie W. Esseltine. A scholar is included among the top collaborators of Dixie W. Esseltine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dixie W. Esseltine. Dixie W. Esseltine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study. | 26 |
| 2 | 236 | |
| 3 | 41 | |
| 4 | Newborn screening for sickle cell and other hemoglobinopathies: a Canadian pilot study. | 11 |
| 5 | 40 | |
| 6 | 26 | |
| 7 | 16 | |
| 8 | 9 | |
| 9 | 26 | |
| 10 | 37 | |
| 11 | 6 | |
| 12 | 3 | |
| 13 | Acute lymphoblastic leukemia at relapse in a child with acute myeloblastic leukemia. | 9 |
| 14 | Growth and development of long-term survivors of childhood acute lymphoblastic leukemia treated with and without prophylactic radiation of the central nervous system. | 14 |
| 15 | 12 | |
| 16 | 12 | |
| 17 | 14 | |
| 18 | 23 | |
| 19 | 26 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.